Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PORACTANT ALFA
- Non Inferiority Trial Investigating Surfactants Administered Via MIST
- Prophylactic Minimally Invasive Surfactant Evaluation
- Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial
- Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)
- Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19
- Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.
- Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
- A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
- Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome
- A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration
- Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS
- A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)
- Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome
- Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations
- Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
Clinical trials list
click for details